journal article·2022-08-31Open access

The Role of Optical Imaging in Translational Nanomedicine

Evelien Hesemans, Kiana Buttiens, Bella Manshian, Stefaan Soenen

Abstract

Nanomedicines have been a major research focus in the past two decades and are increasingly emerging in a broad range of clinical applications. However, a proper understanding of their biodistribution is required to further progress the field of nanomedicine. For this, imaging methods to monitor the delivery and therapeutic efficacy of nanoparticles are urgently needed. At present, optical imaging is the most common method used to study the biodistribution of nanomaterials, where the unique properties of nanomaterials and advances in optical imaging can jointly result in novel methods for optimal monitoring of nanomaterials in preclinical animal models. This review article aims to give an introduction to nanomedicines and their translational impact to highlight the potential of optical imaging to study the biodistribution of nanoparticles and to monitor the delivery and therapeutic efficacy at the preclinical level. After introducing both domains, the review focuses on different techniques that can be used to overcome some intrinsic limitations of optical imaging and how this can specifically benefit nanoparticle studies. Finally, we point out some important key features of nanoparticles that currently hinder their full potential in the clinic and how the advances in optical imaging can help to provide us with the information needed to further boost the clinical translation and expand the field of nanomedicines.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NanoHealth and Optical Imaging Group, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Herestraat 49, B3000 Leuven, Belgium

Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Herestraat 49, B3000 Leuven, Belgium

Leuven Cancer Institute, 3000 Leuven, Belgium

Funding

the Fonds voor Wetenschappelijk Onderzoek (FWO) · the European Commission Horizon 2020 Research Framework · esearch project · KU Leuven BOF funding

References (100+)

Show source-provided references
1. Challenges in nanomedicine clinical translation10.1007/s13346-020-00740-5 ↗
2. Nanoparticles in biomedical applications
3. Nanoparticles with multiple properties for biomedical applications: A strategic guide10.1016/j.nantod.2016.07.002 ↗
4. Nanoparticles in the clinic10.1002/btm2.10003 ↗
5. Jürgen Popp, V.V.T., Chiou, A., and Heinemann, S. (2012). Handbook of Biophotonics, Wiley-VCH Verlag GmbH & Co. KGaA.10.1002/9783527643981 ↗
6. Applications of nanoparticles in biomedical imaging10.1039/C8NR07769J ↗
7. Nanoparticle delivery of cancer drugs10.1146/annurev-med-040210-162544 ↗
8. Personalized medicine and follow-up of therapeutic delivery through exploitation of quantum dot toxicity10.1016/j.biomaterials.2017.02.039 ↗
9. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date10.1007/s11095-016-1958-5 ↗
10. Doxil (R)—The first FDA-approved nano-drug: Lessons learned10.1016/j.jconrel.2012.03.020 ↗
11. Mechanism of hard-nanomaterial clearance by the liver10.1038/nmat4718 ↗
12. Vieira, D.B., and Gamarra, L.F. (2018). Multifunctional Nanoparticles for Successful Targeted Drug Delivery across the Blood-Brain Barrier, IntechOpen.10.5772/intechopen.76922 ↗
13. Nanoparticles in the clinic: An update10.1002/btm2.10143 ↗
14. Fda Advisers Okay Nexstars Daunoxome
15. Marqibo (R) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine10.1007/s00280-012-2042-4 ↗
16. Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet (TM))10.1016/j.breast.2009.05.004 ↗
17. Limited, P.U. (2019, March 04). Summary of Product Characteristics, CosmoFer. Available online: https://www.medicines.org.uk/emc/product/48/smpc.
18. Limited, V.P.U. (2019, March 04). Summary of Product Characteristics, VenoFer. Available online: https://www.medicines.org.uk/emc/product/5911.
19. Sun, J.Y., Kormakov, S., Liu, Y., Huang, Y., Wu, D.M., and Yang, Z.G. (2018). Recent Progress in Metal-Based Nanoparticles Mediated Photodynamic Therapy. Molecules, 23.10.3390/molecules23071704 ↗
20. Nanoparticles for Thermal Cancer Therapy10.1115/1.3156800 ↗
21. Nanoparticles for Advanced Photodynamic Therapy of Cancer10.1089/pho.2017.4308 ↗
22. Delivering the power of nanomedicine to patients today10.1016/j.jconrel.2020.07.007 ↗
23. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design10.1021/acsnano.0c07197 ↗
24. Non-viral COVID-19 vaccine delivery systems10.1016/j.addr.2020.12.008 ↗
25. Accumulation and trafficking of zinc oxide nanoparticles in an invertebrate model, Bombyx mori, with insights on their effects on immuno-competent cells10.1038/s41598-020-58526-1 ↗
26. A general mechanism for intracellular toxicity of metal-containing nanoparticles10.1039/c4nr01234h ↗
27. Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells10.1038/s41598-019-48959-8 ↗
28. TAT-modified nanosilver for combating multidrug-resistant cancer10.1016/j.biomaterials.2012.05.035 ↗
29. Model-Based Nanoengineered Pharmacokinetics of Iron-Doped Copper Oxide for Nanomedical Applications10.1002/anie.201912312 ↗
30. MagForce, A.G. (2019, March 03). The Nanomedicine Company. Available online: https://www.magforce.com/en/home/for_patients/#faq.
31. Recent advances in nanomaterials for enhanced photothermal therapy of tumors10.1039/C8NR07627H ↗
32. Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells10.1177/1010428317734691 ↗
33. Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease10.1177/1091581815600170 ↗
34. RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?10.1146/annurev-pharmtox-010715-103633 ↗
35. Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors10.1038/mt.2013.32 ↗
36. Bawa, R., Szebeni, J., Webster, T.J., and Audette, G.F. (2019). Immune Aspects of Biopharmaceuticals and Nanomedicines, CRC Press.10.1201/b22372 ↗
37. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme10.1016/j.nano.2014.09.005 ↗
38. Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells10.1002/anie.201813149 ↗
39. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone10.1038/nbt1396 ↗
40. A phase I study of MM-302, a HER2-targeted liposomal doxorubicin, in patients with advanced, HER2-positive (HER2+) breast cancer10.1200/jco.2012.30.15_suppl.tps663 ↗
41. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound10.1021/acs.molpharmaceut.6b00013 ↗
42. The success of nanomedicine10.1016/j.nantod.2020.100853 ↗
43. The beginning of the end of the nanomedicine hype10.1016/j.jconrel.2019.05.044 ↗
44. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures10.1021/acs.accounts.9b00228 ↗
45. The entry of nanoparticles into solid tumours10.1038/s41563-019-0566-2 ↗
46. Specific Endothelial Cells Govern Nanoparticle Entry into Solid Tumors10.1021/acsnano.1c04510 ↗
47. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
48. A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics10.1126/sciadv.aay9249 ↗
49. The dose threshold for nanoparticle tumour delivery10.1038/s41563-020-0755-z ↗
50. (2021, March 03). NCI Alliance for Nanotechnology in Cancer, Available online: https://www.cancer.gov/nano/research/alliance.
51. Optical Imaging of the Breast: Basic Principles and Clinical Applications10.2214/AJR.16.17220 ↗
52. BIOIMAGING Second window for in vivo imaging10.1038/nnano.2009.326 ↗
53. Fluorescence Imaging In Vivo at Wavelengths beyond 1500 nm10.1002/anie.201507473 ↗
54. Noninvasive In Vivo Imaging in the Second Near-Infrared Window by Inorganic Nanoparticle-Based Fluorescent Probes10.1021/acs.analchem.9b04156 ↗
55. In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles10.1038/s41587-019-0262-4 ↗
56. Bright quantum dots emitting at similar to 1600 nm in the NIR-IIb window for deep tissue fluorescence imaging10.1073/pnas.1806153115 ↗
57. Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
58. High-resolution, serial intravital microscopic imaging of nanoparticle delivery and targeting in a small animal tumor model10.1016/j.nantod.2013.02.004 ↗
59. Mezzanotte, L., Que, I., Kaijzel, E., Branchini, B., Roda, A., and Lowik, C. (2011). Sensitive Dual Color In Vivo Bioluminescence Imaging Using a New Red Codon Optimized Firefly Luciferase and a Green Click Beetle Luciferase. PLoS ONE, 6.10.1371/journal.pone.0019277 ↗
60. Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources10.1021/ac051999h ↗
61. Xie, B.-W., Mol, I.M., Keereweer, S., Van Beek, E.R., Que, I., Snoeks, T.J.A., Chan, A., Kaijzel, E.L., and Löwik, C.W.G.M. (2012). Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model. PLoS ONE, 7.10.1371/journal.pone.0031875 ↗
62. In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals10.3390/s110100180 ↗
63. A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging10.1038/ncomms11856 ↗
64. The expanding Toolbox of In Vivo Bioluminescent imaging10.3389/fonc.2016.00150 ↗
65. Single-cell bioluminescence imaging of deep tissue in freely moving animals10.1126/science.aaq1067 ↗
66. A synthetic luciferin improves bioluminescence imaging in live mice10.1038/nmeth.2839 ↗
67. Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals10.1038/s41592-020-0889-6 ↗
68. Development of near-infrared firefly luciferin analogue reacted with wild-type and mutant luciferases10.1002/chir.23236 ↗
69. Quantitative in vivo dual-color bioluminescence imaging in the mouse brain10.1117/1.NPh.6.2.025006 ↗
70. Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin10.7554/eLife.45801 ↗
71. Red-shifted click beetle luciferase mutant expands the multicolor bioluminescent palette for deep tissue imaging10.1016/j.isci.2020.101986 ↗
72. Synthesis and characterization of a tumor-seeking LyP-1 peptide integrated lipid-polymer composite nanoparticle10.1039/D0MA00203H ↗
73. Effect of Covalent Fluorescence Labeling of Plasmid DNA on Its Intracellular Processing and Transfection with Lipid-Based Carriers10.1021/mp4003078 ↗
74. Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer10.18632/oncotarget.27193 ↗
75. Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions10.1186/s12951-020-00679-2 ↗
76. Nanoparticle based fluorescence resonance energy transfer (FRET) for biosensing applications10.1039/C5TB00885A ↗
77. Use of Fluorescent Probes: Their Effect on Cell Biology and Limitations10.1002/ar.22602 ↗
78. Theranostic Magnetic Core-Plasmonic Shell Star Shape Nanoparticle for the Isolation of Targeted Rare Tumor Cells from Whole Blood, Fluorescence Imaging, and Photothermal Destruction of Cancer10.1021/mp300468q ↗
79. Naphthalocyanine-Based Biodegradable Polymeric Nanoparticles for Image-Guided Combinatorial Phototherapy10.1021/acs.chemmater.5b03128 ↗
80. A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination10.1002/anie.200705240 ↗
81. Simultaneous imaging of Zn(2+) and Cu(2+) in living cells based on DNAzyme modified gold nanoparticle10.1021/acs.analchem.5b00204 ↗
82. Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging10.1117/1.2032458 ↗
83. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles10.1038/nbt.3987 ↗
84. Self-Assembled Semiconducting Polymer Nanoparticles for Ultrasensitive Near-Infrared Afterglow Imaging of Metastatic Tumors10.1002/adma.201801331 ↗
85. Nonbleaching fluorescence of gold nanoparticles and its applications in cancer cell imaging10.1021/ac8005796 ↗
86. (2014). Bioluminescent Imaging: Methods and Protocols. Methods Mol. Biol., 1098, 1–276.
87. D’Hollander, A., Velde, G.V., Jans, H., Vanspauwen, B., Vermeersch, E., Jose, J., Struys, T., Stakenborg, T., Lagae, L., and Himmelreich, U. (2020). Assessment of the Theranostic Potential of Gold Nanostars-A Multimodal Imaging and Photothermal Treatment Study. Nanomaterials, 10.10.3390/nano10112112 ↗
88. Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles10.3389/fphar.2018.00802 ↗
89. The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy10.1016/j.semradonc.2010.11.004 ↗
90. Tomographic magnetic particle imaging of cancer targeted nanoparticles10.1039/C7NR05502A ↗
91. Multifunctional Transferrin Encapsulated GdF3 Nanoparticles for Sentinel Lymph Node and Tumor Imaging10.1021/acs.bioconjchem.0c00514 ↗
92. Three-Dimensional Optical Mapping of Nanoparticle Distribution in Intact Tissues10.1021/acsnano.6b01879 ↗
93. In vivo cation exchange in quantum dots for tumor-specific imaging
94. Ultralong Phosphorescence of Water-Soluble Organic Nanoparticles for In Vivo Afterglow Imaging10.1002/adma.201606665 ↗
95. Multifunctional in vivo vascular imaging using near-infrared II fluorescence10.1038/nm.2995 ↗
96. Ultrabright NIR-II Emissive Polymer Dots for Metastatic Ovarian Cancer Detection10.1002/advs.202000441 ↗
97. Carbon nanotubes as cancer therapeutic carriers and mediators10.2147/IJN.S112660 ↗
98. Sanginario, A., Miccoli, B., and Demarchi, D. (2017). Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment. Biosensors, 7.10.3390/bios7010009 ↗
99. Simon, J., Flahaut, E., and Golzio, M. (2019). Overview of Carbon Nanotubes for Biomedical Applications. Materials, 12.10.3390/ma12040624 ↗
100. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues10.1038/s41467-018-03505-4 ↗